Curasept ADS I DNA Chlorhexidine: mouthwashes, toothpastes, gels | Curasept

Curasept ADS | DNA

Discover the products

This page is intended for international users only, to access Italian content, please switch to the Italian website on the upper right corner of this web page.

This Brand may be available as “Curasept ADS” in your country. Check with your local distributor.

Curasept ADS I DNA mouthwashes, toothpastes and gels, based on Chlorhexidine, are specific for activating a deep antibacterial and antiseptic action, essential for intervening effectively on bacterial biofilm (bacterial plaque).

Chlorhexidine is the only substance known to date that can act with 4 fundamental interventions on plaque:

INTERVENTION ON ADHESION

Chlorhexidine prevents bacteria from adhering to the surface of the teeth.

INTERVENTION ON COLONIZATION: ANTISEPTIC ACTION

Chlorhexidine, at the usual concentrations of use, has the ability to destroy numerous types of bacteria

INTERVENTION ON DISINTEGRATION

Chlorhexidine, in addition to acting against bacteria, is able to break the chemical bonds of calcium with glycoproteins, effectively disaggregating the structure of plaque in each of its layers.

INTERVENTION ON METABOLISM: SUBSTANTIVITY

After use, Chlorhexidine is gradually released into the oral cavity for approximately 12 hours, allowing for a prolonged action that stimulates the disintegration of plaque layers and the destruction of bacteria throughout the oral cavity, as well as preventing the formation of plaque itself.

ENHANCES THE ANTI-PIGMENTING ACTION
COUNTERS THE CAUSES OF PERIODONTITIS
ACCELERATES HEALING PROCESSES

CURASEPT ADS | DNA INTENSIVE TREATMENT 0.20

CURASEPT ADS | DNA PROLONGED TREATMENT 0.12

CURASEPT ADS | DNA PLAQUE AND CARIES TREATMENT 0.05

Curasept ADS Chlorexidine mouthwashes are available only in Germany in the following HAP version.

Interested in Chlorexidine tailored solutions for specific needs?
Find out more about Curasept ADS DNA Pro Line

DISCOVER THE FULL RANGE

CURASEPT ADS | DNA 720 GEL TOOTHPASTE

CURASEPT ADS | DNA 720 GEL TOOTHPASTE

CURASEPT ADS | DNA 205 MOUTHWASH

CURASEPT ADS | DNA 205 MOUTHWASH

CURASEPT ADS | DNA 212 MOUTHWASH

CURASEPT ADS | DNA 212 MOUTHWASH

CURASEPT ADS | DNA 220 MOUTHWASH

CURASEPT ADS | DNA 220 MOUTHWASH

CURASEPT ADS | DNA 705 GEL TOOTHPASTE

CURASEPT ADS | DNA 705 GEL TOOTHPASTE

CURASEPT ADS | DNA 712 GEL TOOTHPASTE

CURASEPT ADS | DNA 712 GEL TOOTHPASTE

CURASEPT ADS 0.5% GUM TOPICAL TREATMENT SPRAY

CURASEPT ADS 0.5% GUM TOPICAL TREATMENT SPRAY

CURASEPT ADS 1% TOPICAL GUM TREATMENT PERIODONTAL GEL

CURASEPT ADS 1% TOPICAL GUM TREATMENT PERIODONTAL GEL

CURASEPT ADS 350 PERIODONTAL GEL

CURASEPT ADS 350 PERIODONTAL GEL

DISCOVER ALL THE BRANDS

Accessibility Adjustments

Powered by OneTap

Select your accessibility profile

Vision Impaired Mode

Enhances website's visuals

Seizure Safe Profile

Clear flashes & reduces color

ADHD Friendly Mode

Focused browsing, distraction-free

Blindness Mode

Reduces distractions, improves focus

Epilepsy Safe Mode

Dims colors and stops blinking

Content

Colors

Orientation

Quality Policy

The Quality for CURASEPT S.p.A. is an essential condition to put itself successfully on the market, considering its characteristics and evolution.

The development of the Company and its profit are insured by the continuous search for quality towards excellence through the continuous improvement of its processes and the search for partners with quality systems adapted to our standards.

The Company aims to increase the customer satisfaction through the application of its Quality Management System, including the processes to improve the system and to ensure the compliance with the customer and applicable regulatory requirements.

For this purpose, the Company performs specific risks and opportunities assessment activities, connected to the context, stakeholders and related objectives, in order to identify the areas of system improvements and to define the appropriate actions for the risk control and mitigation and strengthening of its Quality System.

The starting point for the implementation of this policy is the pursuit of the following objectives:

Define and implement a Quality Management System according to 9001:2015+A1:2024 e UNI CEI EN ISO 13485:2021 regulation, as Manufacturer of Medical Devices;
Define and implement a system of procedures and operating instructions in harmony with the Directive 93/42/CEE, the Regulation (UE) 2017/745 and the Regulation (UE) 2023/607 for the applicable parts and subsequent changes and integrations, which satisfy the essential requirements set out in Annex I;
Define and implement a system of procedures in harmony with the Directive 2010/84, the Regulation 1235/2010, the Implementation Regulation n. 520/2012 and in accordance with the objectives of “module I – “Good Vigilance Practices” (GVP);
Establish and formalize the business organizational structure with the subdivision into areas of competences;
Clarify roles and responsibilities of business functions;
Define strategies and objectives and assign human and material resources for their achievement;
Define accurately business processes and related performance factors;
Ensure compliance with qualitative, quantitative and temporal requirements;
Constantly monitor the level of adequacy of the system with reference to regulations and laws;
Promote initiatives in order to improve the process of motivational and professional growth of human resources, considered as critical resources for future business developments;
Ensure the commitment to the satisfaction of requirements and the maintenance of effectiveness of the Quality Management System.

These objectives can be realized thanks to the involvement of the whole Company personnel.

In particular, the Managers of each Function provide their contribution so that the suggested improvements can be proposed to the General Direction, so that the Quality Policy can be a priority element in the choice of business qualitative and organizational strategies.

The involvement of the whole personnel in the improvement of internal and external processes should be aimed at reducing non-compliance and internal and external costs of non-quality; for this reason all employees should feel themselves committed in pursuing this policy.

Training courses, for all business levels, are promoted and planned by the General Direction in order to keep the personnel constantly up to date on the improvements performed for the processes.

The Quality Manual, which is distributed via the SistemaQualità to all process managers and the General Director, should represent a work tool for all Managers and their personnel for the implementation of the Quality Policy.

April 2025

General Direction